Surgical castration of β-catenin-stabilized or Apc-depleted PBCre4-driven prostate cancer models at a timepoint when tumors are prevalent causes CRPC despite some initial partial sensitivity, indicating activation of the Wnt pathway promotes CRPC growth [181,184]. This evidence concerns the gene APC and prostate carcinoma.